Extended-Release Niacin or Ezetimibe and Carotid Intima-Media Thickness
Taylor et al.
NEJM 2009;361:2113-2122.
ABSTRACT
| FULL TEXT
Bile Acids and Metabolic Regulation: Mechanisms and clinical responses to bile acid sequestration
Staels and Fonseca
Diabetes Care 2009;32:S237-S245.
FULL TEXT
High-density Lipoprotein Cholesterol: Current Perspective for Clinicians
Whayne
ANGIOLOGY 2009;60:644-649.
ABSTRACT
Response to Letter of Mascitelli L, Ravnskov U, Pezzetta F, and Goldstein M
Whayne
ANGIOLOGY 2009;60:129-130.
Impact of Statin Use on Outcomes After Coronary Artery Bypass Graft Surgery
Kulik et al.
Circulation 2008;118:1785-1792.
ABSTRACT
| FULL TEXT
Intensive Lipid-Lowering With Atorvastatin for Secondary Prevention in Patients After Coronary Artery Bypass Surgery
Shah et al.
J Am Coll Cardiol 2008;51:1938-1943.
ABSTRACT
| FULL TEXT
Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus Conference Report From the American Diabetes Association and the American College of Cardiology Foundation
Brunzell et al.
J Am Coll Cardiol 2008;51:1512-1524.
FULL TEXT
Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation
Brunzell et al.
Diabetes Care 2008;31:811-822.
FULL TEXT
Patterns and predictors of statin use after coronary artery bypass graft surgery.
Kulik et al.
J. Thorac. Cardiovasc. Surg. 2007;134:932-938.
ABSTRACT
| FULL TEXT
High-Density Lipoprotein as a Therapeutic Target: A Systematic Review
Singh et al.
JAMA 2007;298:786-798.
ABSTRACT
| FULL TEXT
Biomarkers in the Prevention and Treatment of Atherosclerosis: Need, Validation, and Future
Revkin et al.
Pharmacol. Rev. 2007;59:40-53.
ABSTRACT
| FULL TEXT
Rational therapy of mixed dyslipidaemia in a patient with diabetes
Reasner
British Journal of Diabetes & Vascular Disease 2007;7:25-30.
ABSTRACT
Reducing risk by raising HDL-cholesterol: the evidence
Drexel
Eur Heart J Suppl 2006;8:F23-F29.
ABSTRACT
| FULL TEXT
Niaspan(R) in the management of dyslipidaemia: the evidence
Brown
Eur Heart J Suppl 2006;8:F60-F67.
ABSTRACT
| FULL TEXT
Maximizing coronary disease risk reduction using nicotinic acid combined with LDL-lowering therapy
Brown
Eur Heart J Suppl 2005;7:F34-F40.
ABSTRACT
| FULL TEXT
Statin Initiation Following Coronary Artery Bypass Grafting: Outcome of a Hospital Discharge Protocol
Khanderia et al.
Chest 2005;127:455-463.
ABSTRACT
| FULL TEXT
Effects of exercise and diet on chronic disease
Roberts and Barnard
J. Appl. Physiol. 2005;98:3-30.
ABSTRACT
| FULL TEXT
Addressing Cardiovascular Disease in Women: Focus on Dyslipidemia
Meagher
J Am Board Fam Med 2004;17:424-437.
ABSTRACT
| FULL TEXT
Future Looks Promising for the Treatment of Patients With Coronary Heart Disease
Clearfield
JAOA: Journal of the American Osteopathic Association 2004;104:1S-2S.
FULL TEXT
A comparison of oxidized LDL-induced collagen secretion by graft and aortic SMCs: role of PDGF
Absood et al.
Am. J. Physiol. Heart Circ. Physiol. 2004;287:H1200-H1206.
ABSTRACT
| FULL TEXT
New Perspectives on the Use of Niacin in the Treatment of Lipid Disorders
McKenney
Arch Intern Med 2004;164:697-705.
ABSTRACT
| FULL TEXT
Review: Use of nicotinic acid in patients with elevated fasting glucose, diabetes, or metabolic syndrome
Mcgovern
British Journal of Diabetes & Vascular Disease 2004;4:78-85.
ABSTRACT
Prediction of Short-Term Progression or Regression of Atherosclerotic Coronary Artery Disease by Lipoprotein (a): A Quantitative Coronary Angiographic Study
Uchida et al.
ANGIOLOGY 2003;54:641-646.
ABSTRACT
CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans
Chandler et al.
J. Lipid Res. 2003;44:1887-1901.
ABSTRACT
| FULL TEXT
Patterns of Secondary Prevention in Older Patients Undergoing Coronary Artery Bypass Grafting During Hospitalization for Acute Myocardial Infarction
Foody et al.
Circulation 2003;108:II-24-28.
ABSTRACT
| FULL TEXT
Hormone Therapy and the Progression of Coronary-Artery Atherosclerosis in Postmenopausal Women
Hodis et al.
NEJM 2003;349:535-545.
ABSTRACT
| FULL TEXT
Niacin as a Component of Combination Therapy for Dyslipidemia
Miller
Mayo Clin Proc. 2003;78:735-742.
ABSTRACT
Prevention of Cardiovascular Ischemic Events: High-Risk and Secondary Prevention
Genest and Pedersen
Circulation 2003;107:2059-2065.
FULL TEXT
References
Circulation 2002;106:3373-3421.
FULL TEXT
Combination therapy: its rationale and the role of ezetimibe
Stone
Eur Heart J Suppl 2002;4:J19-J22.
ABSTRACT
Effects of a Contemporary, Exercise-Based Rehabilitation and Cardiovascular Risk-Reduction Program on Coronary Patients With Abnormal Baseline Risk Factors*
Franklin et al.
Chest 2002;122:338-343.
ABSTRACT
| FULL TEXT
Niacin, but Not Gemfibrozil, Selectively Increases LP-AI, a Cardioprotective Subfraction of HDL, in Patients With Low HDL Cholesterol
Sakai et al.
Arterioscler. Thromb. Vasc. Bio. 2001;21:1783-1789.
ABSTRACT
| FULL TEXT
Cardiac Rehabilitation and Secondary Prevention of Coronary Heart Disease
Ades
NEJM 2001;345:892-902.
FULL TEXT
Impact of social support, cynical hostility and anger expression on progression of coronary atherosclerosis
Angerer et al.
J Am Coll Cardiol 2000;36:1781-1788.
ABSTRACT
| FULL TEXT
Prognostic factors for atherosclerosis progression in saphenous vein grafts: The postcoronary artery bypass graft (post-CABG) trial
Domanski et al.
J Am Coll Cardiol 2000;36:1877-1883.
ABSTRACT
| FULL TEXT
Effect of Niacin on Lipid and Lipoprotein Levels and Glycemic Control in Patients With Diabetes and Peripheral Arterial Disease: The ADMIT Study: A Randomized Trial
Elam et al.
JAMA 2000;284:1263-1270.
ABSTRACT
| FULL TEXT
Gemfibrozil, nicotinic acid and combination therapy in patients with isolated hypoalphalipoproteinemia: a randomized, open-label, crossover study
Zema
J Am Coll Cardiol 2000;35:640-646.
ABSTRACT
| FULL TEXT
Cardiovascular risk in women: the cardiologist's perspective
EDMUNDS and LIP
QJM 2000;93:135-145.
FULL TEXT
In Vivo Uptake of Radiolabeled MDA2, an Oxidation-Specific Monoclonal Antibody, Provides an Accurate Measure of Atherosclerotic Lesions Rich in Oxidized LDL and Is Highly Sensitive to Their Regression
Tsimikas et al.
Arterioscler. Thromb. Vasc. Bio. 2000;20:689-697.
ABSTRACT
| FULL TEXT
Estimating the Long-Term Effects of Storage at -70 {degrees}C on Cholesterol, Triglyceride, and HDL-Cholesterol Measurements in Stored Sera
Shih et al.
Clin. Chem. 2000;46:351-364.
ABSTRACT
| FULL TEXT
An Evidence-Based Assessment of the NCEP Adult Treatment Panel II Guidelines
Ansell et al.
JAMA 1999;282:2051-2057.
ABSTRACT
| FULL TEXT
Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The Cholesterol Lowering Atherosclerosis PTCA Trial (CLAPT)
Kleemann et al.
Eur Heart J 1999;20:1393-1406.
ABSTRACT
Colesevelam Hydrochloride (Cholestagel): A New, Potent Bile Acid Sequestrant Associated With a Low Incidence of Gastrointestinal Side Effects
Davidson et al.
Arch Intern Med 1999;159:1893-1900.
ABSTRACT
| FULL TEXT
Increased Cerebral CO2 Reactivity After Heparin-Mediated Extracorporal LDL Precipitation (HELP) in Patients With Coronary Heart Disease and Hyperlipidemia
Pfefferkorn et al.
Stroke 1999;30
:e1802-1806.
ABSTRACT
| FULL TEXT
Drug Treatment of Lipid Disorders
Knopp
NEJM 1999;341:498-511.
FULL TEXT
Improvement of Impaired Myocardial Vasodilatation Due to Diffuse Coronary Atherosclerosis in Hypercholesterolemics After Lipid-Lowering Therapy
Yokoyama et al.
Circulation 1999;100:117-122.
ABSTRACT
| FULL TEXT
Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations
Flaker et al.
J Am Coll Cardiol 1999;34:106-112.
ABSTRACT
| FULL TEXT
Aggressive Cholesterol Lowering Delays Saphenous Vein Graft Atherosclerosis in Women, the Elderly, and Patients With Associated Risk Factors : NHLBI Post Coronary Artery Bypass Graft Clinical Trial
Campeau et al.
Circulation 1999;99:3241-3247.
ABSTRACT
| FULL TEXT
High apolipoprotein AI concentrations are associated with lower mortality and myocardial infarction five years after coronary artery bypass graft surgery
Skinner et al.
Heart 1999;81:488-494.
ABSTRACT
| FULL TEXT
Plasminogen Is Not Required for Neointima Formation in a Mouse Model of Vein Graft Stenosis
Shi et al.
Circ. Res. 1999;84:883-890.
ABSTRACT
| FULL TEXT
The Effect of Dietary {omega}-3 Fatty Acids on Coronary Atherosclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial
von Schacky et al.
ANN INTERN MED 1999;130:554-562.
ABSTRACT
| FULL TEXT
Forecasting Patient Outcomes in the Management of Hyperlipidemia
Brier et al.
Arch Intern Med 1999;159:569-575.
ABSTRACT
| FULL TEXT
Lowering LDL Cholesterol : Questions From Recent Meta-Analyses and Subset Analyses of Clinical Trial DataIssues From the Interdisciplinary Council on Reducing the Risk for Coronary Heart Disease, Ninth Council Meeting
Gotto and Grundy
Circulation 1999;99
:e1-e7.
ABSTRACT
| FULL TEXT
Systematic Review on the Risk and Benefit of Different Cholesterol-Lowering Interventions
Bucher et al.
Arterioscler. Thromb. Vasc. Bio. 1999;19:187-195.
ABSTRACT
| FULL TEXT
Strategies to achieve coronary arterial plaque stabilization
Rabbani and Topol
Cardiovasc Res 1999;41:402-417.
ABSTRACT
| FULL TEXT
Coronary artery surgery: the end of the beginning
Loop
Eur. J. Cardiothorac. Surg. 1998;14:554-571.
ABSTRACT
| FULL TEXT
Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT)
Ruotolo et al.
J Am Coll Cardiol 1998;32:1648-1656.
ABSTRACT
| FULL TEXT
Inhibition of Ileal Na+/Bile Acid Cotransporter by S-8921 Reduces Serum Cholesterol and Prevents Atherosclerosis in Rabbits
Higaki et al.
Arterioscler. Thromb. Vasc. Bio. 1998;18:1304-1311.
ABSTRACT
| FULL TEXT
Joint British recommendations on prevention of coronary heart disease in clinical practice
British Cardiac Society et al.
Heart 1998;80:1S-29.
FULL TEXT
Effective Lipid Modification by Partial Ileal Bypass Reduced Long-term Coronary Heart Disease Mortality and Morbidity: Five-Year Posttrial Follow-up Report From the POSCH
Buchwald et al.
Arch Intern Med 1998;158:1253-1261.
ABSTRACT
| FULL TEXT
Effects of Lowering Average or Below-Average Cholesterol Levels on the Progression of Carotid Atherosclerosis : Results of the LIPID Atherosclerosis Substudy
MacMahon et al.
Circulation 1998;97:1784-1790.
ABSTRACT
| FULL TEXT
Prediction of Coronary Heart Disease Using Risk Factor Categories
Wilson et al.
Circulation 1998;97:1837-1847.
ABSTRACT
| FULL TEXT
Perspectives in the Treatment of Dyslipidemias in the Prevention of Coronary Heart Disease
Borgia and Medici
ANGIOLOGY 1998;49:339-348.
ABSTRACT
Cholesterol Reduction Yields Clinical Benefit : Impact of Statin Trials
Gould et al.
Circulation 1998;97:946-952.
ABSTRACT
| FULL TEXT
Aortocoronary Saphenous Vein Graft Disease : Pathogenesis, Predisposition, and Prevention
Motwani and Topol
Circulation 1998;97:916-931.
ABSTRACT
| FULL TEXT
Echo-Lucency of Computerized Ultrasound Images of Carotid Atherosclerotic Plaques Are Associated With Increased Levels of Triglyceride-Rich Lipoproteins as Well as Increased Plaque Lipid Content
Gronholdt et al.
Circulation 1998;97:34-40.
ABSTRACT
| FULL TEXT
Mechanism of Hypocholesterolemic Action of S-8921 in Rats: S-8921 Inhibits Ileal Bile Acid Absorption
Ichihashi et al.
J. Pharmacol. Exp. Ther. 1998;284:43-50.
ABSTRACT
| FULL TEXT
Cafestol, the Cholesterol-Raising Factor in Boiled Coffee, Suppresses Bile Acid Synthesis by Downregulation of Cholesterol 7{alpha}-Hydroxylase and Sterol 27-Hydroxylase in Rat Hepatocytes
Post et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:3064-3070.
ABSTRACT
| FULL TEXT
Prevention of the Angiographic Progression of Coronary and Vein-Graft Atherosclerosis by Gemfibrozil After Coronary Bypass Surgery in Men With Low Levels of HDL Cholesterol
Frick et al.
Circulation 1997;96:2137-2143.
ABSTRACT
| FULL TEXT
Niacin Decreases Removal of High-Density Lipoprotein Apolipoprotein A-I But Not Cholesterol Ester by Hep G2 Cells : Implication for Reverse Cholesterol Transport
Jin et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:2020-2028.
ABSTRACT
| FULL TEXT
Adherence to National Cholesterol Education Program Treatment Goals in Postmenopausal Women With Heart Disease: The Heart and Estrogen/Progestin Replacement Study (HERS)
Schrott et al.
JAMA 1997;277:1281-1286.
ABSTRACT
Hypobetalipoproteinemia Is Associated With Low Levels of Hemostatic Risk Factors in the Framingham Offspring Population
Welty et al.
Circulation 1997;95:825-830.
ABSTRACT
| FULL TEXT
The Effect of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation on Obstructive Changes in Saphenous-Vein Coronary-Artery Bypass Grafts
The Post Coronary Artery Bypass Graft Trial Invest
NEJM 1997;336:153-163.
ABSTRACT
| FULL TEXT
Echolucent Carotid Artery Plaques Are Associated With Elevated Levels of Fasting and Postprandial Triglyceride-Rich Lipoproteins
Gronholdt et al.
Stroke 1996;27:2166-2172.
ABSTRACT
| FULL TEXT
Effect of Supplementary Antioxidant Vitamin Intake on Carotid Arterial Wall Intima-Media Thickness in a Controlled Clinical Trial of Cholesterol Lowering
Azen et al.
Circulation 1996;94:2369-2372.
ABSTRACT
| FULL TEXT
Serum Lipids and Incidence of Coronary Heart Disease: Findings From the Systolic Hypertension in the Elderly Program (SHEP)
Frost et al.
Circulation 1996;94:2381-2388.
ABSTRACT
| FULL TEXT
Clinical Trial of Wax-Matrix Sustained-Release Niacin in a Russian Population With Hypercholesterolemia
Aronov et al.
Arch Fam Med 1996;5:567-575.
ABSTRACT
Predominance of Dense Low-Density Lipoprotein Particles Predicts Angiographic Benefit of Therapy in the Stanford Coronary Risk Intervention Project
Miller et al.
Circulation 1996;94:2146-2153.
ABSTRACT
| FULL TEXT
Assessing the Independent Effect of Dietary Counseling and Hypolipidemic Medications on Serum Lipids
Fleming et al.
ANGIOLOGY 1996;47:831-840.
ABSTRACT
Effects of Cigarette Smoking on the Angiographic Evolution of Coronary Atherosclerosis: A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy
Waters et al.
Circulation 1996;94:614-621.
ABSTRACT
| FULL TEXT
Improvement of Atherosclerosis and Stiffness of the Thoracic Descending Aorta With Cholesterol-Lowering Therapies in Familial Hypercholesterolemia
Tomochika et al.
Arterioscler. Thromb. Vasc. Bio. 1996;16:955-962.
ABSTRACT
| FULL TEXT
EXTERNAL STENTING REDUCES EARLY MEDIAL AND NEOINTIMAL THICKENING IN A PIG MODEL OF ARTERIOVENOUS BYPASS GRAFTING
Angelini et al.
J. Thorac. Cardiovasc. Surg. 1996;112:79-84.
ABSTRACT
| FULL TEXT
The Influence of Angiographic Endpoints on the Outcome of Lipid Intervention Studies: A Proposal for Standardization
Wouter Jukema et al.
ANGIOLOGY 1996;47:633-642.
ABSTRACT
Meta-analysis, Clinical Trials, and Transferability of Research Results Into Practice: The Case of Cholesterol-Lowering Interventions in the Secondary Prevention of Coronary Heart Disease
Marchioli et al.
Arch Intern Med 1996;156:1158-1172.
ABSTRACT
Effectiveness of Low-Dose Crystalline Nicotinic Acid in Men With Low High-Density Lipoprotein Cholesterol Levels
Martin-Jadraque et al.
Arch Intern Med 1996;156:1081-1088.
ABSTRACT
LDL-Apheresis Atherosclerosis Regression Study (LAARS) : Effect of Aggressive Versus Conventional Lipid Lowering Treatment on Coronary Atherosclerosis
Kroon et al.
Circulation 1996;93:1826-1835.
ABSTRACT
| FULL TEXT
Evidence for a Synergistic Effect of Calcium Channel Blockers With Lipid-Lowering Therapy in Retarding Progression of Coronary Atherosclerosis in Symptomatic Patients With Normal to Moderately Raised Cholesterol Levels
Jukema et al.
Arterioscler. Thromb. Vasc. Bio. 1996;16:425-430.
ABSTRACT
| FULL TEXT
Effects of Colestipol Alone and in Combination With Simvastatin on Apolipoprotein B Metabolism
Gaw et al.
Arterioscler. Thromb. Vasc. Bio. 1996;16:236-249.
ABSTRACT
| FULL TEXT
Atherosclerosis and Risk Factor Modification: Does It Really Make a Difference?
Corson et al.
PERSPECT VASC SURG ENDOVASC THER 1996;9:75-94.
Progression of Coronary Artery Disease Predicts Clinical Coronary Events : Long-term Follow-up From the Cholesterol Lowering Atherosclerosis Study
Azen et al.
Circulation 1996;93:34-41.
ABSTRACT
| FULL TEXT
Treating Hyperlipidemia in the Elderly
Fleming et al.
ANGIOLOGY 1995;46:1075-1083.
ABSTRACT
Hyperlipidemia and Coronary Disease : Correction of the Increased Thrombogenic Potential With Cholesterol Reduction
Lacoste et al.
Circulation 1995;92:3172-3177.
ABSTRACT
| FULL TEXT
Plasma HDL Cholesterol, Triglycerides, and Adiposity : A Quantitative Genetic Test of the Conjoint Trait Hypothesis in the San Antonio Family Heart Study
Mahaney et al.
Circulation 1995;92:3240-3248.
ABSTRACT
| FULL TEXT
Late Outcome After Coronary Artery Bypass Graft Surgery in Patients <40 Years Old
French et al.
Circulation 1995;92:14-19.
ABSTRACT
| FULL TEXT
Effects of Cholesterol Lowering on the Progression of Coronary Atherosclerosis in Women : A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy
Waters et al.
Circulation 1995;92:2404-2410.
ABSTRACT
| FULL TEXT
Kuopio Atherosclerosis Prevention Study (KAPS) : A Population-Based Primary Preventive Trial of the Effect of LDL Lowering on Atherosclerotic Progression in Carotid and Femoral Arteries
Salonen et al.
Circulation 1995;92:1758-1764.
ABSTRACT
| FULL TEXT
